| Name | Quin C1 |
|---|---|
| Synonyms |
quin-C1
Benzamide, 4-butoxy-N-[1,4-dihydro-2-(4-methoxyphenyl)-4-oxo-3(2H)-quinazolinyl]- 4-Butoxy-N-[2-(4-methoxyphenyl)-4-oxo-1,4-dihydro-3(2H)-quinazolinyl]benzamide 4-Butoxy-N-[1,4-dihydro-2-(4-methoxyphenyl)-4-oxo-3(2H)-quinazolinyl]benzamide 4-butoxy-N-(2-(4-methoxy-phenyl)-4-oxo-1,4-dihydro-2H-quinazolin-3-yl)-benzamide |
| Description | Quin C1 is a highly specific and potent agonist for formyl peptide receptor 2 (FPR2/ALX). Quin-C1 significantly reduces the neutrophil and lymphocyte counts in BALF, diminishes expression of TNF-α, IL-1β, KC, and TGF-β1, and decreases collagen deposition in lung tissue. Quin C1 has the potential for the research of lung injury[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C26H27N3O4 |
| Molecular Weight | 445.51 |
| Exact Mass | 445.200165 |
| LogP | 2.79 |
| Index of Refraction | 1.645 |